Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PERFLUOROHEXYLOCTANE vs PERTUZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PERFLUOROHEXYLOCTANE vs PERTUZUMAB: Safety Overview

Metric PERFLUOROHEXYLOCTANE PERTUZUMAB
Total FAERS Reports 870 21,995
Deaths Reported 31 2,161
Death Rate 3.6% 9.8%
Hospitalizations 58 7,803
Average Patient Age 71.2 yrs 55.8 yrs
% Female Patients 82.8% 95.9%
FDA Approval Date May 18, 2023 N/A
Manufacturer Bausch & Lomb Incorporated Genentech, Inc.
Route OPHTHALMIC INTRAVENOUS
Marketing Status Prescription Prescription